Allogene Therapeutics Inc (ALLO)
R&D Expenses
$30.72M
Quarterly · Period ending: · USD
ALLO R&D Expenses
Latest reported$30.72Mperiod ending
Latest reported$30.72Mperiod ending
ALLO Quarterly R&D Expenses ($0.00 → $30.72M)
Quarterly R&D Expenses
High-resolution chart · PNG
ALLO r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 30,721,000 | |
| 32,003,000 | |
| 28,632,000 | |
| 31,164,000 | |
| 40,156,000 | |
| 50,200,000 | |
| 44,972,000 | |
| 44,713,000 | |
| 50,355,000 | |
| 52,259,000 | |
| 54,661,000 | |
| 45,977,000 | |
| 62,038,000 | |
| 80,238,000 | |
| 75,419,000 | |
| 63,641,000 | |
| 57,171,000 | |
| 60,156,000 | |
| 53,983,000 | |
| 58,720,000 | |
| 52,290,000 | |
| 55,183,000 | |
| 52,228,000 | |
| 51,421,000 | |
| 47,296,000 | |
| 42,042,000 | |
| 49,363,000 | |
| 39,995,000 | |
| 31,774,000 | |
| 23,403,000 | |
| 18,504,000 | |
| 10,870,000 | |
| 122,486,000 | |
| 0 | |
| 0 |